Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Caffeine and coffee as therapeutics against Alzheimer's disease.

Arendash GW, Cao C.

J Alzheimers Dis. 2010;20 Suppl 1:S117-26. doi: 10.3233/JAD-2010-091249. Review.

PMID:
20182037
2.

Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.

Steiner H, Capell A, Leimer U, Haass C.

Eur Arch Psychiatry Clin Neurosci. 1999;249(6):266-70. Review.

PMID:
10653281
3.

Therapeutic potential of gamma-secretase inhibitors and modulators.

Imbimbo BP.

Curr Top Med Chem. 2008;8(1):54-61. Review.

PMID:
18220933
5.

beta-Secretase, APP and Abeta in Alzheimer's disease.

Vassar R.

Subcell Biochem. 2005;38:79-103. Review.

PMID:
15709474
6.

Gamma-secretase inhibitors for Alzheimer's disease: balancing efficacy and toxicity.

Barten DM, Meredith JE Jr, Zaczek R, Houston JG, Albright CF.

Drugs R D. 2006;7(2):87-97. Review.

PMID:
16542055
7.

Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.

Conway KA, Baxter EW, Felsenstein KM, Reitz AB.

Curr Pharm Des. 2003;9(6):427-47. Review.

PMID:
12570807
8.

Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.

Dewachter I, van Dorpe J, Spittaels K, Tesseur I, Van Den Haute C, Moechars D, Van Leuven F.

Exp Gerontol. 2000 Sep;35(6-7):831-41. Review.

PMID:
11053674
9.
11.

REVIEW: Curcumin and Alzheimer's disease.

Hamaguchi T, Ono K, Yamada M.

CNS Neurosci Ther. 2010 Oct;16(5):285-97. doi: 10.1111/j.1755-5949.2010.00147.x. Review.

PMID:
20406252
12.

Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline.

Cunha RA, Agostinho PM.

J Alzheimers Dis. 2010;20 Suppl 1:S95-116. doi: 10.3233/JAD-2010-1408. Review.

PMID:
20182043
13.

Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.

Panza F, Solfrizzi V, Barulli MR, Bonfiglio C, Guerra V, Osella A, Seripa D, Sabbà C, Pilotto A, Logroscino G.

J Nutr Health Aging. 2015 Mar;19(3):313-28. doi: 10.1007/s12603-014-0563-8. Review.

PMID:
25732217
14.

Caffeine, diabetes, cognition, and dementia.

Biessels GJ.

J Alzheimers Dis. 2010;20 Suppl 1:S143-50. doi: 10.3233/JAD-2010-091228. Review.

PMID:
20182038
15.

Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease.

Carman AJ, Dacks PA, Lane RF, Shineman DW, Fillit HM.

J Nutr Health Aging. 2014 Apr;18(4):383-92. doi: 10.1007/s12603-014-0021-7. Review.

PMID:
24676319
16.

Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease.

Heneka MT, Kummer MP, Weggen S, Bulic B, Multhaup G, Münter L, Hüll M, Pflanzner T, Pietrzik CU.

Curr Alzheimer Res. 2011 Mar;8(2):115-31. Review.

PMID:
21345168
17.

The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis.

Hooijmans CR, Pasker-de Jong PC, de Vries RB, Ritskes-Hoitinga M.

J Alzheimers Dis. 2012;28(1):191-209. doi: 10.3233/JAD-2011-111217. Review.

PMID:
22002791
18.

Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties.

Papadopoulos V, Lecanu L.

J Neuroendocrinol. 2012 Jan;24(1):93-101. doi: 10.1111/j.1365-2826.2011.02167.x. Review.

PMID:
21623958
19.

Caffeine: neuroprotective functions in cognition and Alzheimer's disease.

Rosso A, Mossey J, Lippa CF.

Am J Alzheimers Dis Other Demen. 2008 Oct-Nov;23(5):417-22. Review.

PMID:
19230121
20.

Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.

Benedict C, Frey WH 2nd, Schiöth HB, Schultes B, Born J, Hallschmid M.

Exp Gerontol. 2011 Feb-Mar;46(2-3):112-5. doi: 10.1016/j.exger.2010.08.026. Epub 2010 Sep 16. Review.

PMID:
20849944

Supplemental Content

Support Center